NO20076355L - Dengue serotype 1 attenuert stamme - Google Patents
Dengue serotype 1 attenuert stammeInfo
- Publication number
- NO20076355L NO20076355L NO20076355A NO20076355A NO20076355L NO 20076355 L NO20076355 L NO 20076355L NO 20076355 A NO20076355 A NO 20076355A NO 20076355 A NO20076355 A NO 20076355A NO 20076355 L NO20076355 L NO 20076355L
- Authority
- NO
- Norway
- Prior art keywords
- dengue serotype
- attenuated strain
- strain
- vdv1
- dengue
- Prior art date
Links
- 208000001490 Dengue Diseases 0.000 title abstract 3
- 206010012310 Dengue fever Diseases 0.000 title abstract 3
- 208000025729 dengue disease Diseases 0.000 title abstract 3
- 230000002238 attenuated effect Effects 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 210000003501 vero cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
- C12N2770/24164—Methods of inactivation or attenuation by serial passage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69124305P | 2005-06-17 | 2005-06-17 | |
| PCT/IB2006/001313 WO2006134433A1 (en) | 2005-06-17 | 2006-05-18 | Dengue serotype 1 attenuated strain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20076355L true NO20076355L (no) | 2008-03-11 |
Family
ID=36933493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20076355A NO20076355L (no) | 2005-06-17 | 2007-12-12 | Dengue serotype 1 attenuert stamme |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US7641907B2 (pt) |
| EP (1) | EP1893637B1 (pt) |
| JP (1) | JP5197362B2 (pt) |
| KR (2) | KR101536612B1 (pt) |
| CN (1) | CN101238144B (pt) |
| AR (1) | AR053913A1 (pt) |
| AU (1) | AU2006257610B2 (pt) |
| BR (1) | BRPI0613328A2 (pt) |
| CA (1) | CA2611934C (pt) |
| IL (1) | IL188041A0 (pt) |
| MX (1) | MX2007015873A (pt) |
| MY (1) | MY144689A (pt) |
| NO (1) | NO20076355L (pt) |
| TW (1) | TWI414605B (pt) |
| WO (1) | WO2006134433A1 (pt) |
| ZA (1) | ZA200710714B (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005519639A (ja) | 2002-01-15 | 2005-07-07 | アカンビス インコーポレーティッド | フラビウイルスワクチン |
| US7968102B2 (en) * | 2006-01-13 | 2011-06-28 | Sanofi Pasteur S.A. | Dengue chimeric viruses |
| FR2903605A1 (fr) * | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| FR2909286B1 (fr) * | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| ES2615390T3 (es) | 2008-03-05 | 2017-06-06 | Sanofi Pasteur | Proceso para estabilizar una composición de vacuna que contiene adyuvante |
| EP2143440A1 (fr) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
| WO2011026139A1 (en) | 2009-08-31 | 2011-03-03 | Gen-Probe Incorporated | Dengue virus assay |
| CA2878599A1 (en) * | 2012-07-24 | 2014-01-30 | Jiansheng Yao | Vaccine compositions for prevention against dengue virus infection |
| MY168959A (en) | 2012-07-24 | 2019-01-28 | Sanofi Pasteur | Vaccine compositions for the prevention of dengue virus infection |
| BR112015012515B1 (pt) | 2012-11-30 | 2023-04-11 | Sanofi Pasteur | Uso de antígenos, construções de ácido nucleico ou vetores virais capazes de expressar uma partícula do tipo vírus (vlp) da dengue e de uma vacina contra sarampo, uma vacina contra caxumba e uma vacina contra rubéola |
| JP2016504315A (ja) * | 2012-12-14 | 2016-02-12 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 三価デングウイルス製剤に関する組成物、投与方法および使用 |
| CA3177572C (en) | 2013-03-15 | 2026-02-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for dengue virus chimeric constructs in vaccines |
| MX366154B (es) | 2013-06-21 | 2019-06-28 | Merck Sharp & Dohme | Composiciones de vacuna del virus del dengue y metodos de uso de las mismas. |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| MY192543A (en) | 2014-12-22 | 2022-08-26 | Merck Sharp & Dohme | Dengue virus vaccine compositions and methods of use thereof |
| US10857222B2 (en) | 2015-07-03 | 2020-12-08 | Sanofi Pasteur | Concomitant dengue and yellow fever vaccination |
| NZ782252A (en) * | 2015-11-27 | 2025-12-19 | Km Biologics Co Ltd | Live virus having a bank of dengue virus attenuated strains, and a dengue vaccine containing same as antigens |
| AU2018346724B2 (en) | 2017-10-05 | 2025-01-09 | Sanofi Pasteur | Compositions for booster vaccination against dengue |
| US12318439B2 (en) * | 2021-05-09 | 2025-06-03 | Board Of Regents, The University Of Texas System | Attenuating viral mutations in protein genes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6093296A (en) | 1995-06-07 | 1996-12-30 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
| AU779280B2 (en) * | 1999-03-26 | 2005-01-13 | Walter Reed Army Institute Of Research | Multivalent dengue virus vaccine |
| CA2941182A1 (en) * | 2000-02-16 | 2001-08-23 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Avirulent, immunogenic flavivirus chimeras |
| PT1159968E (pt) * | 2000-05-30 | 2008-11-20 | Univ Mahidol | Estirpes atenuadas de vírus do dengue e a sua utilização numa composição de vacina |
| ES2327103T3 (es) | 2000-09-25 | 2009-10-26 | Polymun Scientific Immunbiologische Forschung Gmbh | Vacuna viva de influenzavirus y procedimiento de fabricacion. |
| EP1402075B1 (en) | 2001-05-22 | 2012-11-14 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, the Department of Health and Human Services, | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| HUE037330T2 (hu) * | 2002-05-03 | 2018-08-28 | The Government Of The Us Secretary Department Of Health And Human Services | rDEN3/4delta30(ME), rDEN2/4delta30(ME) vagy rDEN1/4delta30(ME) rekombináns kiméra dengue virus, amely 30 nukleotidos deléciót tartalmaz (delta 30) a 4-es típusú dengue genom 3' nem-transzlálódó régiójában, ahol a szóban forgó 30 nukleotidos deléció megfelel a TL2 nyél-hurok szerkezetnek |
| JP4537045B2 (ja) * | 2003-12-11 | 2010-09-01 | キヤノン株式会社 | 電子ペーパー、電子ペーパー接続装置、システム、電子ペーパーにおける制御方法及びコンピュータプログラム |
-
2006
- 2006-05-18 WO PCT/IB2006/001313 patent/WO2006134433A1/en not_active Ceased
- 2006-05-18 CN CN2006800284986A patent/CN101238144B/zh not_active Expired - Fee Related
- 2006-05-18 EP EP06744729.2A patent/EP1893637B1/en not_active Expired - Lifetime
- 2006-05-18 MX MX2007015873A patent/MX2007015873A/es active IP Right Grant
- 2006-05-18 AU AU2006257610A patent/AU2006257610B2/en not_active Ceased
- 2006-05-18 JP JP2008516427A patent/JP5197362B2/ja not_active Expired - Fee Related
- 2006-05-18 KR KR1020137034846A patent/KR101536612B1/ko not_active Expired - Fee Related
- 2006-05-18 CA CA2611934A patent/CA2611934C/en not_active Expired - Fee Related
- 2006-05-18 BR BRPI0613328-2A patent/BRPI0613328A2/pt not_active IP Right Cessation
- 2006-06-08 MY MYPI20062663A patent/MY144689A/en unknown
- 2006-06-09 US US11/449,876 patent/US7641907B2/en active Active
- 2006-06-16 TW TW095121647A patent/TWI414605B/zh not_active IP Right Cessation
- 2006-06-16 AR ARP060102566A patent/AR053913A1/es unknown
-
2007
- 2007-12-10 ZA ZA200710714A patent/ZA200710714B/xx unknown
- 2007-12-11 IL IL188041A patent/IL188041A0/en not_active IP Right Cessation
- 2007-12-12 NO NO20076355A patent/NO20076355L/no not_active Application Discontinuation
-
2008
- 2008-01-17 KR KR1020087001412A patent/KR101464649B1/ko not_active Expired - Fee Related
-
2009
- 2009-12-08 US US12/633,411 patent/US8067565B2/en active Active
-
2011
- 2011-10-25 US US13/281,240 patent/US9169298B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006257610A1 (en) | 2006-12-21 |
| IL188041A0 (en) | 2008-03-20 |
| CA2611934C (en) | 2015-11-03 |
| KR20080027356A (ko) | 2008-03-26 |
| US20060292172A1 (en) | 2006-12-28 |
| CN101238144A (zh) | 2008-08-06 |
| JP2008546382A (ja) | 2008-12-25 |
| AU2006257610B2 (en) | 2012-11-15 |
| CN101238144B (zh) | 2012-09-05 |
| US9169298B2 (en) | 2015-10-27 |
| US20120083584A1 (en) | 2012-04-05 |
| TW200741002A (en) | 2007-11-01 |
| CA2611934A1 (en) | 2006-12-21 |
| KR20140006119A (ko) | 2014-01-15 |
| KR101464649B1 (ko) | 2014-12-01 |
| AR053913A1 (es) | 2007-05-23 |
| KR101536612B1 (ko) | 2015-07-14 |
| WO2006134433A1 (en) | 2006-12-21 |
| JP5197362B2 (ja) | 2013-05-15 |
| TWI414605B (zh) | 2013-11-11 |
| EP1893637A1 (en) | 2008-03-05 |
| EP1893637B1 (en) | 2016-01-06 |
| ZA200710714B (en) | 2008-11-26 |
| US7641907B2 (en) | 2010-01-05 |
| US8067565B2 (en) | 2011-11-29 |
| BRPI0613328A2 (pt) | 2011-01-04 |
| MX2007015873A (es) | 2008-04-22 |
| US20100137571A1 (en) | 2010-06-03 |
| MY144689A (en) | 2011-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20076360L (no) | Dengue serotype 2 attenuert stamme | |
| TW200741002A (en) | Dengue serotype 1 attenuated strain | |
| SG159542A1 (en) | Compositions against sars-coronavirus and uses thereof | |
| EA200900676A1 (ru) | Ингибиторы вируса гепатита с | |
| NO20090194L (no) | Rekombinant viral vaksine | |
| EA201171174A1 (ru) | Ингибиторы репликации вируса гепатита c | |
| NO20092053L (no) | HCV NS3-proteaseinhibitorer | |
| NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
| NO20084850L (no) | MGLUR5 modulatorer I | |
| EP2419095A4 (en) | ACTIVE COMPOSITIONS USING MODULATORS OF OXIDATIVE STRESS (OSM), NEW CHEMICAL ACTIVE SUBSTANCES, COMPOSITIONS AND USES | |
| NO20074885L (no) | N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus | |
| WO2010053573A3 (en) | Screen for inhibitors of filovirus and uses therefor | |
| SG170751A1 (en) | Extractions and methods comprising elder species | |
| BRPI1015043A2 (pt) | derivados de diazahomoadamantano e métodos de uso dos mesmos | |
| CY1114562T1 (el) | Υψηλης καθαροτητας μεγαλης κλιμακας παρασκευη στανσοπορφινης | |
| NO20082909L (no) | Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene | |
| NO20083065L (no) | Nye N-sulfamoylpiperidinamider for profylakse eller behandling av overvekt og beslektede tilstander | |
| NO20082704L (no) | Hepatitt C virusvarianter | |
| DK1965809T3 (da) | Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner | |
| WO2010088222A3 (en) | A high molecular weight polysaccharide that binds and inhibits virus | |
| IL187915A0 (en) | 1,2-di(cyclic group)substituted benzene derivative | |
| NO20074136L (no) | Orale sammensetninger for forebygging av UV-skader | |
| NO20091386L (no) | Fenyloksyanilinderivater | |
| WO2007002587A3 (en) | Inhibitors of epstein barr virus nuclear antigen 1 | |
| NO20081235L (no) | Benzotiadiazolyfenylalkylaminderivater for anvendelse for behandling av lidelser lindret av monoamin reopptak |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |